Biernacki, T.; Kokas, Z.; Sandi, D.; Füvesi, J.; Fricska-Nagy, Z.; Faragó, P.; Kincses, T.Z.; Klivényi, P.; Bencsik, K.; Vécsei, L.
Emerging Biomarkers of Multiple Sclerosis in the Blood and the CSF: A Focus on Neurofilaments and Therapeutic Considerations. Int. J. Mol. Sci. 2022, 23, 3383.
https://doi.org/10.3390/ijms23063383
AMA Style
Biernacki T, Kokas Z, Sandi D, Füvesi J, Fricska-Nagy Z, Faragó P, Kincses TZ, Klivényi P, Bencsik K, Vécsei L.
Emerging Biomarkers of Multiple Sclerosis in the Blood and the CSF: A Focus on Neurofilaments and Therapeutic Considerations. International Journal of Molecular Sciences. 2022; 23(6):3383.
https://doi.org/10.3390/ijms23063383
Chicago/Turabian Style
Biernacki, Tamás, Zsófia Kokas, Dániel Sandi, Judit Füvesi, Zsanett Fricska-Nagy, Péter Faragó, Tamás Zsigmond Kincses, Péter Klivényi, Krisztina Bencsik, and László Vécsei.
2022. "Emerging Biomarkers of Multiple Sclerosis in the Blood and the CSF: A Focus on Neurofilaments and Therapeutic Considerations" International Journal of Molecular Sciences 23, no. 6: 3383.
https://doi.org/10.3390/ijms23063383
APA Style
Biernacki, T., Kokas, Z., Sandi, D., Füvesi, J., Fricska-Nagy, Z., Faragó, P., Kincses, T. Z., Klivényi, P., Bencsik, K., & Vécsei, L.
(2022). Emerging Biomarkers of Multiple Sclerosis in the Blood and the CSF: A Focus on Neurofilaments and Therapeutic Considerations. International Journal of Molecular Sciences, 23(6), 3383.
https://doi.org/10.3390/ijms23063383
